Typicality: | 0.649 |
Saliency: | 0.696 |
in place | 30 | location |
for the approval of biosimilars | 8 | purpose |
so far | 6 | temporal |
country → have → regulation | 477 |
country → be → regulation | 22 |
country → need → regulation | 6 |
country → bring → regulation | 4 |
negative | neutral | positive |
0.215 | 0.673 | 0.112 |
Raw frequency | 509 |
Normalized frequency | 0.696 |
Modifier score | 0.812 |
Perplexity | 148.254 |